Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Cep-40783 | 1437321-24-8 | 99.6% | 588.56 g/mol | C31H26F2N4O6 | 500 MG
SDP

Catalog No. 5000211645
Encompass_Preferred

CEP-40783 is a potent, selective, orally available small-molecule inhibitor of the receptor tyrosine kinases AXL and c-Met. It exhibits low-nanomolar biochemical and cellular activity and is intended for preclinical research on RTK signaling and oncology models.

  • Potent dual inhibition of AXL and c-Met at low nanomolar concentrations.
  • Demonstrated cellular activity in transfected and tumor cell lines.
  • High purity suitable for biochemical and cellular assays.
  • Powder stable at -20°C for long-term storage; solutions stable at -80°C.
  • Available in a 500 mg package size for research use.

Catalog No. 50-002-11645 Supplier Medchemexpress LLC Supplier No. HY100946500MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

CEP-40783 is a potent, selective, orally available small-molecule inhibitor of the receptor tyrosine kinases AXL and c-Met. It exhibits low-nanomolar biochemical and cellular activity and is intended for preclinical research on RTK signaling and oncology models.

  • Potent dual inhibition of AXL and c-Met at low nanomolar concentrations.
  • Demonstrated cellular activity in transfected and tumor cell lines.
  • High purity suitable for biochemical and cellular assays.
  • Powder stable at -20°C for long-term storage; solutions stable at -80°C.
  • Available in a 500 mg package size for research use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.